Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Net Cash Flow (2016 - 2026)

Wave Life Sciences (WVE) has disclosed Net Cash Flow for 12 consecutive years, with -$57.5 million as the latest value for Q1 2026.

  • For Q1 2026, Net Cash Flow rose 2.68% year-over-year to -$57.5 million; the TTM value through Mar 2026 reached $301.6 million, up 384.78%, while the annual FY2025 figure was $300.0 million, 194.35% up from the prior year.
  • Net Cash Flow hit -$57.5 million in Q1 2026 for Wave Life Sciences, down from $405.9 million in the prior quarter.
  • Across five years, Net Cash Flow topped out at $405.9 million in Q4 2025 and bottomed at -$88.8 million in Q1 2022.
  • Average Net Cash Flow over 5 years is $23.2 million, with a median of -$19.3 million recorded in 2024.
  • On a YoY basis, Net Cash Flow climbed as much as 4737.5% in 2025 and fell as far as 205.34% in 2025.
  • Wave Life Sciences' Net Cash Flow stood at -$8.5 million in 2022, then surged by 806.46% to $60.4 million in 2023, then crashed by 114.5% to -$8.8 million in 2024, then soared by 4737.5% to $405.9 million in 2025, then tumbled by 114.16% to -$57.5 million in 2026.
  • According to Business Quant data, Net Cash Flow over the past three periods came in at -$57.5 million, $405.9 million, and -$12.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.